← Back to Trial

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Trial Locations

• Duarte Cancer Center Duarte, California, United States
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• Lennar Foundation Cancer Center Irvine, California, United States
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• UCI Health Chao Family Comprehensive Cancer Center Orange, California, United States
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• Stanford University Palo Alto, California, United States
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• University of California San Francisco, California, United States
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• Chicago Cancer Center Zion, Illinois, United States
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• MD Anderson Cancer Center Houston, Texas, United States
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• NEXT Virginia Fairfax, Virginia, United States
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• AU61002 Darlinghurst, Australia
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• AU61001 Melbourne, Australia
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• ES34001 Barcelona, Spain
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• ES34007 Barcelona, Spain
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• ES34015 Barcelona, Spain
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• ES34010 Logroño, Spain
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• ES34003 Madrid, Spain
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• ES34012 Madrid, Spain
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• ES34013 Málaga, Spain
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• ES34004 Pamplona, Spain
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• ES34002 Pozuelo de Alarcón, Spain
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• ES34005 Sabadell, Spain
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• ES34009 Valencia, Spain
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• GB44003 Leicester, United Kingdom
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)
• GB44001 London, United Kingdom
  • Contact: Astellas Pharma Global Development, Inc · 800-888-7704 · [email protected] (opens in new tab)